Gilbert Lynn Marks
Director · 2 filings · Latest: Apr 10, 2026
AN2 Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
ANTX | Gilbert Lynn Marks | Director | Apr 10, 2026 | Grant/Award | $0.00 | 3,775 | — | 79,084 |